Protopic and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Protopic (tacrolimus) and Fluocinonide (fluocinonide). Common drug interactions include breast cancer among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Protopic and Fluocinonide. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Protopic?

Protopic has active ingredients of tacrolimus. It is often used in eczema. eHealthMe is studying from 5,403 Protopic users. Check the latest studies of Protopic.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.



On Aug, 11, 2026

87 people who take Protopic and Fluocinonide together, and have interactions are studied.

Protopic and Fluocinonide drug interactions.

What are the common drug interactions of Protopic and Fluocinonide, by gender? *:

female:

  1. Breast cancer
  2. Dry eye (lack of adequate tears)
  3. Dry skin
  4. Insomnia (sleeplessness)
  5. Skin burning sensation
  6. Skin cancer
  7. Anxiety
  8. Chronic kidney disease
  9. Infection
  10. Nasal dryness (dry nose)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Corneal abrasion (loss of the surface of cornea)
  4. Disturbance in attention
  5. Foreign body in eye (foreign particle in eye)
  6. Joint dislocation (a joint position is changed from normal position)
  7. Oesophagitis (inflammation of oesophagus)
  8. Painful respiration
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pruritus (severe itching of the skin)

What are the common drug interactions of Protopic and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Asthma
  3. Bone marrow failure
  4. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  5. Diarrhoea

10-19:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  3. Erythema (redness of the skin)
  4. Hypersensitivity
  5. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Oligomenorrhoea (infrequent (or, in occasional usage, very light) menstruation)
  8. Overdose
  9. Pruritus (severe itching of the skin)
  10. Pyrexia (fever)

20-29:

  1. Rash
  2. Fatigue (feeling of tiredness)
  3. Lymphadenopathy (disease or enlargement of lymph nodes)
  4. Pruritus (severe itching of the skin)
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Chest pain
  7. Corneal abrasion (loss of the surface of cornea)
  8. Disturbance in attention
  9. Dyspnoea (difficult or laboured respiration)
  10. Foreign body in eye (foreign particle in eye)

30-39:

  1. Rash
  2. Anxiety
  3. Back pain
  4. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  5. Drug toxicity
  6. Dry skin
  7. Ear pain
  8. Gynaecomastia (enlargement of the gland tissue of the male breast)
  9. Hodgkin's disease (cancer originating from white blood cells)
  10. Hypersensitivity

40-49:

  1. Rash
  2. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  3. Discomfort
  4. Nasal dryness (dry nose)
  5. Therapeutic response decreased (less preventive response)
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Drug ineffective
  8. Ear pain
  9. Erythema (redness of the skin)
  10. Eye inflammation

50-59:

  1. Renal disorder (kidney disease)
  2. Renal failure (kidney dysfunction)
  3. Skin burning sensation
  4. Skin discomfort (skin pain/irritation)
  5. Therapeutic response decreased (less preventive response)
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  9. Depressed mood
  10. Exophthalmos (bulging or protruding eyeball)

60+:

  1. Erythema (redness of the skin)
  2. Hypertension (high blood pressure)
  3. Ataxia (loss of full control of bodily movements)
  4. Back pain
  5. Body tinea (ringworm of the body)
  6. Bone marrow failure
  7. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  8. Cellulitis (infection under the skin)
  9. Cervicobrachial syndrome (pain in neck and arm with changing location)
  10. Concussion (short loss of normal brain function in response to a head injury)

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 25 people, 28.74%
  2. Psoriasis (immune-mediated disease that affects the skin): 13 people, 14.94%
  3. Pain: 8 people, 9.20%
  4. Rashes (redness): 6 people, 6.90%
  5. High Blood Pressure: 5 people, 5.75%
  6. High Blood Cholesterol: 5 people, 5.75%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.75%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Protopic and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Protopic and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Protopic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Protopic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and fluocinonide (the active ingredients of Protopic and Fluocinonide, respectively), and Protopic and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: